Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Express Scripts
Novartis
Cerilliant
Medtronic
Queensland Health
Dow
Teva
Healthtrust

Generated: October 22, 2017

DrugPatentWatch Database Preview

Vorapaxar sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for vorapaxar sulfate and what is the scope of vorapaxar sulfate patent protection?

Vorapaxar sulfate
is the generic ingredient in one branded drug marketed by Aralez Pharms and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Vorapaxar sulfate has one hundred and sixty patent family members in thirty-six countries and thirteen supplementary protection certificates in ten countries.

Two suppliers are listed for this compound.

Summary for Generic Name: vorapaxar sulfate

US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Clinical Trials: see list672
Drug Prices:see low prices
DailyMed Link:vorapaxar sulfate at DailyMed

Pharmacology for Ingredient: vorapaxar sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aralez Pharms
ZONTIVITY
vorapaxar sulfate
TABLET;ORAL204886-001May 8, 2014RXYesYes► Subscribe► SubscribeYY ► Subscribe
Aralez Pharms
ZONTIVITY
vorapaxar sulfate
TABLET;ORAL204886-001May 8, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Aralez Pharms
ZONTIVITY
vorapaxar sulfate
TABLET;ORAL204886-001May 8, 2014RXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: vorapaxar sulfate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,645,987 Nor-seco himbacine derivatives useful as thrombin receptor antagonists► Subscribe
7,488,742Thrombin receptor antagonists► Subscribe
7,713,999Thrombin receptor antagonists► Subscribe
6,894,065 Thrombin receptor antagonists► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: vorapaxar sulfate

Country Document Number Estimated Expiration
South Korea101039973► Subscribe
Spain2338171► Subscribe
South Africa200605550► Subscribe
TaiwanI331608► Subscribe
Japan2007056043► Subscribe
Russian Federation2367660► Subscribe
Australia2003221932► Subscribe
European Patent Office2065384► Subscribe
China1436185► Subscribe
Norway20044963► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: VORAPAXAR SULFATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015027,C1495018Lithuania► SubscribePRODUCT NAME: VORAPAKSARAS; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150119
2015 00037Denmark► SubscribePRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING VORAPAXARSULPHATE; REG. NO/DATE: EU/1/14/976/001-06 20150119
0746Netherlands► SubscribePRODUCT NAME: VORAPAXAR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT, IN HET BIJZONDER VORAPAXARSULFAAT; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150121
2015 00037Denmark► SubscribePRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING VORAPAXARSULPHATE; REG. NO/DATE: EU/1/14/976/001-06 20150119
500036Hungary► SubscribePRODUCT NAME: VORAPAXAR; REGISTRATION NO/DATE: EU/1/14/976 20150119
8 50011-2015Slovakia► SubscribePRODUCT NAME: VORAPAXARIUMSULFAT; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150121
2015027Lithuania► SubscribePRODUCT NAME: VORAPAXARUM; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150119
2015000053Germany► SubscribePRODUCT NAME: VORAPAXAR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119
C0047France► SubscribePRODUCT NAME: VORAPAXAR,OU L'UN DE SES SELS OU SOLVATES PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150121
00746Netherlands► SubscribePRODUCT NAME: VORAPAXAR IN ELKE DOOR HET; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
US Department of Justice
Accenture
UBS
Daiichi Sankyo
Boehringer Ingelheim
Covington
Cipla
Healthtrust
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot